Investigating Micro-Manipulation Procedures for Assisted Hatching Timing - Trial NCT06377917
Access comprehensive clinical trial information for NCT06377917 through Pure Global AI's free database. This phase not specified trial is sponsored by Reproductive Medicine Associates of New Jersey and is currently Not yet recruiting. The study focuses on Infertility. Target enrollment is 75 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Reproductive Medicine Associates of New Jersey
Timeline & Enrollment
N/A
May 01, 2024
May 01, 2026
Primary Outcome
Blastulation Rate
Summary
This study aims to assess the clinical significance of cleavage stage (Day 3) assisted
 hatching compared to assisted hatching at the blastocyst stage (Day 5,6,7) of embryo
 development at the time of trophectoderm (TE) biopsy for patients undergoing in vitro
 fertilization (IVF) and preimplantation genetic testing for aneuploidy (PGT-A) for treatment
 of their infertility.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06377917
Non-Device Trial

